-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
Diagnosis and treatment of prostate cancer-related bone disease
Tilman Todenhoefer, Georgios Gakis, David Schilling, Gerhard Feil, Christian Schwentner,Arnulf Stenzl
Review Article: Clinical Investigation
-
Diagnosis and treatment of prostate cancer-related bone disease
Tilman Todenhoefer, Georgios Gakis, David Schilling, Gerhard Feil, Christian Schwentner,Arnulf Stenzl
Review Article: Clinical Investigation
-
Diagnosis and treatment of prostate cancer-related bone disease
Tilman Todenhoefer, Georgios Gakis, David Schilling, Gerhard Feil, Christian Schwentner,Arnulf Stenzl
Review Article: Clinical Investigation
-
Diagnosis and treatment of prostate cancer-related bone disease
Tilman Todenhoefer, Georgios Gakis, David Schilling, Gerhard Feil, Christian Schwentner,Arnulf Stenzl
Review Article: Clinical Investigation
-
Diagnosis and treatment of prostate cancer-related bone disease
Tilman Todenhoefer, Georgios Gakis, David Schilling, Gerhard Feil, Christian Schwentner,Arnulf Stenzl
Review Article: Clinical Investigation
-
Diagnosis and treatment of prostate cancer-related bone disease
Tilman Todenhoefer, Georgios Gakis, David Schilling, Gerhard Feil, Christian Schwentner,Arnulf Stenzl
Review Article: Clinical Investigation